Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Spine J. 2013 Dec 1;14(6):1017–1028. doi: 10.1016/j.spinee.2013.11.034

Table 4.

Gene expression of BMP-2.

Treatment Group Time Point (Ratio to Control ± Standard Deviation)
2 Weeks 4 Weeks 8 Weeks 12 Weeks
Saline + 5 mg/mL simvastatin 9.14 ± 0.83 6.63 ± 0.79 2.20 ± 1.23
Saline + 15 mg/mL simvastatin 27.41 ± 0.02 3.11 ±0.33 1.91 ± 0.88 1.22 ± 0.10
Hydrogel + 5 mg/mL simvastatin 1.84 ± 0.91 1.45 ± 0.12 7.82 ± 2.78
Hydrogel + 15 mg/mL simvastatin 1.86 ± 0.20 1.21 ± 0.52